Matches in Wikidata for { <http://www.wikidata.org/entity/Q77894641> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q77894641 description "artikull shkencor i botuar më 01 janar 1998" @default.
- Q77894641 description "artículu científicu espublizáu en xineru de 1998" @default.
- Q77894641 description "im Jahr 1998 veröffentlichter wissenschaftlicher Artikel" @default.
- Q77894641 description "scientific article published on 01 January 1998" @default.
- Q77894641 description "wetenschappelijk artikel" @default.
- Q77894641 description "наукова стаття, опублікована в січні 1998" @default.
- Q77894641 name "Premarketing studies in the drug approval process: understanding their limitations regarding the assessment of drug safety" @default.
- Q77894641 name "Premarketing studies in the drug approval process: understanding their limitations regarding the assessment of drug safety" @default.
- Q77894641 name "Premarketing studies in the drug approval process: understanding their limitations regarding the assessment of drug safety" @default.
- Q77894641 type Item @default.
- Q77894641 label "Premarketing studies in the drug approval process: understanding their limitations regarding the assessment of drug safety" @default.
- Q77894641 label "Premarketing studies in the drug approval process: understanding their limitations regarding the assessment of drug safety" @default.
- Q77894641 label "Premarketing studies in the drug approval process: understanding their limitations regarding the assessment of drug safety" @default.
- Q77894641 prefLabel "Premarketing studies in the drug approval process: understanding their limitations regarding the assessment of drug safety" @default.
- Q77894641 prefLabel "Premarketing studies in the drug approval process: understanding their limitations regarding the assessment of drug safety" @default.
- Q77894641 prefLabel "Premarketing studies in the drug approval process: understanding their limitations regarding the assessment of drug safety" @default.
- Q77894641 P1433 Q77894641-C83E8A73-DABC-4780-9CD0-E4F751F0044B @default.
- Q77894641 P1476 Q77894641-7A7D9446-D723-41D0-BD0B-92EDC6E2EE4B @default.
- Q77894641 P2093 Q77894641-36030D33-1F47-4DB3-8B30-5F9500FCCE50 @default.
- Q77894641 P304 Q77894641-520E0467-5D41-4537-A0C5-5AB86A777B86 @default.
- Q77894641 P31 Q77894641-9E594EA0-8AEC-4D15-A050-ABE62A5C83F7 @default.
- Q77894641 P31 Q77894641-a1490e6b-ba38-4fdf-adc3-7ba54ec566f0 @default.
- Q77894641 P356 Q77894641-2D95143F-889E-4C6C-BC35-E3513A168A60 @default.
- Q77894641 P478 Q77894641-44DD48CC-0CF5-4900-AA05-A4617A866913 @default.
- Q77894641 P577 Q77894641-DDE29E6E-FDBA-477C-BA6F-721F8432814E @default.
- Q77894641 P698 Q77894641-4E03FA51-6CAD-4EB6-B798-66111070B032 @default.
- Q77894641 P356 S0149-2918(98)80003-9 @default.
- Q77894641 P698 9915085 @default.
- Q77894641 P1433 Q15716601 @default.
- Q77894641 P1476 "Premarketing studies in the drug approval process: understanding their limitations regarding the assessment of drug safety" @default.
- Q77894641 P2093 "T Laughren" @default.
- Q77894641 P304 "C12-9" @default.
- Q77894641 P31 Q13442814 @default.
- Q77894641 P31 Q7318358 @default.
- Q77894641 P356 "10.1016/S0149-2918(98)80003-9" @default.
- Q77894641 P478 "20 Suppl C" @default.
- Q77894641 P577 "1998-01-01T00:00:00Z" @default.
- Q77894641 P698 "9915085" @default.